Another study of 23 paired samples revealed ALK mutations in 30.4% at diagnosis and 43.5% at relapse, however, the small patient number limits its informative value on ALK mutation frequencies in relapsed neuroblastoma, and no attempts to assess sub-clonality had been made [40]. Here, ALK is linked to neuroblastoma.